FDA Inspection
MedisourceRxMedisourceRx – FDA Inspection, Jun 10, 2025
Record Details
This FDA Inspection record concerns MedisourceRx, with an inspection on June 10, 2025, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 5e1c7664-e512-4a49-832f-44a69404210a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1272492
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
- 21 CFR 310.305(c)Failure to submit ADE report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of MedisourceRx
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 4, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 22, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2018 | Not classified | Los Angeles District Office | Drug Quality Assurance |
Other documents for MedisourceRx
- FDA Inspection 1191700 - 2022-11-04
- FDA Inspection 1131719 - 2020-10-22
- FDA Inspection 1067011 - 2018-09-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.